title: [Promotion of HBeAg seroconversion/loss in patients with chronic hepatitis B following the switch from nucleoside drugs to telbivudine and adefovir].
authors.forename: Sunan
authors.initials: S
authors.lastname: Cui
authors.forename: Mingming
authors.initials: M
authors.lastname: Wang
authors.forename: Yanxue
authors.initials: Y
authors.lastname: Gong
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D006513:Hepatitis B e Antigens / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use*; D009705:Nucleosides / Q000037:antagonists & inhibitors* / Q000096:biosynthesis*; D063065:Organophosphonates / Q000627:therapeutic use*; D000077712:Telbivudine; D013936:Thymidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D004338:Drug Combinations; D006513:Hepatitis B e Antigens; D019384:Nucleic Acid Synthesis Inhibitors; D009705:Nucleosides; D063065:Organophosphonates; D000077712:Telbivudine; C053001:adefovir; D000225:Adenine; D013936:Thymidine